EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Blockade of HMGB1 Reduces Inflammation and Pruritus in Atopic Dermatitis by Inhibiting Skin Fibroblasts Activation

Lingxuan Zhou, Xiaohui Yuan, Yongyan Hu, Siyu Zhu, Junxiang Li, Chenyu Wang, Miao Jing, Lingling Liu, Zhe Xu, Zuotao Zhao, Jiahui Zhao

International Archives of Allergy and Immunology · 2024

DOI: 10.1159/000534568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Lingxuan Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research …. Hauptthemen laut MEDLINE: Dermatitis, Atopic, HMGB1 Protein. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by relapsed eczema and serious pruritus. High-mobility group box 1 protein (HMGB1) is a nuclear-binding protein and serves as an alarmin to promote inflammatory responses.

Methods

In this study, we established an AD mouse model by topical use of MC903 on ears and then used a specific HMGB1-binding peptide cIY8 and a HMGB1 inhibitor of glycyrrhizin to investigate HMGB1 on fibroblast activation in the pathogenesis of AD-like symptoms.

Results

Topical use of cIY8 and oral use of glycyrrhizin significantly improved the MC903-induced AD-like symptoms and pathological changes of the ears and scratching behavior in an AD mouse model; cIY8 treatment inhibited the higher mRNAs of IL-1α, IL-4, IL-5, IL-13, and IL-31 in the ears. In human fibroblasts, HMGB1 caused nuclear translocation of NF-kB, and the nuclear translocation could be inhibited by pre-treatment of HMGB1 with cIY8, suggesting that NF-κB signaling pathway participates in the HMGB1-induced inflammation of AD in fibroblasts and that cIY8 effectively impedes the function of HMGB1. Glycyrrhizin inhibited the Ca2+ signaling induced by ionomycin in mouse primary fibroblasts. The fibroblast-related proteins of α-SMA, Hsp47, and vimentin and the pruritus-related proteins of IL-33 and periostin were increased in the ears of the AD mouse model, the ratio of EdU incorporation became higher in mouse fibroblasts treated with MC903, and the higher proliferation and inflammatory responses of the fibroblasts could be reversed by glycyrrhizin treatment.

Conclusions

Fibroblast activation by HMGB1 is one of the critical processes in the development of inflammation and pruritus in the AD mouse model. The specific HMGB1-binding peptide cIY8 and the HMGB1 inhibitor glycyrrhizin inactivate skin fibroblasts to alleviate the inflammation and pruritus in the AD mouse model. Peptide cIY8 may be topically used to treat AD patients in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHMGB1 ProteinAnimalsHumansMiceCytokinesGlycyrrhizic AcidInflammationInterleukin-13NF-kappa BPruritusSkin

Stichwörter der Autor:innen

Atopic dermatitisFibroblastHMGB1 antagonistInflammationPruritus

Substanzen

CytokinesGlycyrrhizic AcidHMGB1 ProteinInterleukin-13NF-kappa BHMGB1 protein, humanHMGB1 protein, mouse

Autor:innen und Institutionen

  • Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Disease, NMPA Key Laboratory for Quality Co…
  • Laboratory Animal Facility, Peking University First Hospital, Beijing, China.
  • AGECODE R&D Center, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, China.
  • Harvest Biotech (Zhejiang) Co., Ltd., Jiaxing, China.
  • Chinese Institute for Brain Research, Beijing, China.
  • Basic Medical Sciences, Capital Medical University, Beijing, China.

Zitieren

APA

Zhou, L., Yuan, X., Hu, Y., Zhu, S., Li, J., Wang, C., Jing, M., Liu, L., Xu, Z., Zhao, Z., & Zhao, J. (2024). Blockade of HMGB1 Reduces Inflammation and Pruritus in Atopic Dermatitis by Inhibiting Skin Fibroblasts Activation. International Archives of Allergy and Immunology. https://doi.org/10.1159/000534568

Vancouver

Zhou L, Yuan X, Hu Y, Zhu S, Li J, Wang C, et al. Blockade of HMGB1 Reduces Inflammation and Pruritus in Atopic Dermatitis by Inhibiting Skin Fibroblasts Activation. International Archives of Allergy and Immunology. 2024. doi:10.1159/000534568

BibTeX
@article{Zhou2024,
  author = {Zhou, Lingxuan and Yuan, Xiaohui and Hu, Yongyan and Zhu, Siyu and Li, Junxiang and Wang, Chenyu and Jing, Miao and Liu, Lingling and Xu, Zhe and Zhao, Zuotao and Zhao, Jiahui},
  title = {Blockade of HMGB1 Reduces Inflammation and Pruritus in Atopic Dermatitis by Inhibiting Skin Fibroblasts Activation},
  journal = {International Archives of Allergy and Immunology},
  year = {2024},
  doi = {10.1159/000534568}
}
Kostenlos starten →